12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Company News  |  Other News

GlaxoSmithKline endocrine/metabolic news

GlaxoSmithKline entered into a consent judgment with 38 state attorneys general to resolve allegations the pharma illegally promoted diabetes drug Avandia rosiglitazone. The pharma agreed to pay $90 million and post...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >